Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.LIMR Chemical Genomics Center (LCGC), a subsidiary of Lankenau Institute for Medical Research (LIMR) has won the Grand Challenges Explorations grant, which is an initiative funded by the Bill & Melinda Gates Foundation.
Subscribe to our email newsletter
LCGC president, CSO and founder Melvin Reichman will begin a new global health and development research project, titled "A Totally New Approach to Discover Malaria Combination Drugs.”
Reichman said that the Grand Challenges Explorations Award offers the project team an opportunity to apply LCGC’s screening technologies to discover novel, combination-drug leads against drug-resistant malaria.
The research project is one of over 80 Grand Challenges Explorations Round 9 grants from the Bill & Melinda Gates Foundation.
Bill & Melinda Gates Foundation global health discovery and translational sciences director Chris Wilson said, "We continue to be impressed by the novelty and innovative spirit of Grand Challenges Explorations projects and are enthusiastic about this exciting research."
The LCGC will develop and validate a new, drug-screening paradigm to detect drug synergy against Plasmodium falciparum using antimalarials and has named the technology as ‘ultra-High Throughput Screening for Synergy’.